Sale!

Kimmtrak(Tebentafusp-tebn) 100 mcg/0.5 mL injection | Best Sales

$18,000.00

Kimmtrak (tebentafusp) is a member of the bispecific T-cell engagers (BiTE) drug class and is commonly used for Uveal Melanoma.

Category: Specialty Medicines

Description

Kimmtrak(Tebentafusp-tebn) 100 mcg/0.5 mL injection | Best Sales

Kimmtrak(Tebentafusp-tebn) is a bispecific gp100 peptide-HLA-directed CD3 T cell engager recommended for adult patients with metastatic or incurable uveal melanoma who test positive for HLA-A*02:01.

Kimmtrak(Tebentafusp-tebn) Recommended Dosage:

The recommended dosing schedule involves administering 20 mcg intravenously on the first day, 30 mcg on the eighth day, 68 mcg on the fifteenth day, and then 68 mcg weekly thereafter. Dilute the medication and administer it via intravenous infusion lasting 15-20 minutes.

Skin reactions such as rash, itching, and swelling of the skin have been observed in patients receiving Tebentafusp-tebn. Should these reactions arise, their management should be based on the persistence and severity of the symptoms.
Increases in liver enzymes have been noted in patients undergoing KIMMTRAK treatment. Monitoring of ALT, AST, and total bilirubin levels is recommended.
Regarding embryo-fetal toxicity, there is a potential risk of harm to the fetus. Patients should be informed about this risk, particularly those of reproductive potential, and advised to use effective contraception methods.

Tebentafusp-tebn is a member of the bispecific T-cell engagers (BiTE) drug class and is commonly used for Uveal Melanoma.

The cost for Tebentafusp-tebn (tebn 100 mcg/0.5 mL) intravenous solution is around $21,343 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Tebentafusp-tebn Coupons, Copay Cards and Rebates

Kimmtrak offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

No manufacturer promotions could be found for this medication.

Patient Assistance & Copay Programs for Tebentafusp-tebn

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:

*See Additional Information section below
Between 400-500% of FPL
FDA Approved Diagnosis – See Program Website for Details
Must reside and receive treatment in US
*Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

Kimmtrak (tebentafusp-tebn) Injection; IV

Provider: Tebentafusp-tebn CONNECT

Eligibility requirements:

Must be uninsured or underinsured
At or below 600% of FPL
FDA-approved diagnosis
Must be residing in the US or Puerto Rico
Your KIMMTRAK CONNECT dedicated nurse case manager will provide educational and logistical support as well as discuss financial assistance options that are available for you. KIMMTRAK CONNECT also offers a Patient Assistance Program (PAP) for eligible patients.

Applicable drugs: